PMID: 8956997Dec 1, 1996Paper

Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins

Genes & Development
G HateboerR L Beijersbergen

Abstract

E2F transcription factors are key regulators of transcription during the cell cycle. E2F activity is regulated at the level of transcription and DNA binding and by complex formation with the retinoblastoma pocket protein family. We show here that free E2F-1 and E2F-4 transcription factors are unstable and that their degradation is mediated by the ubiquitin-proteasome pathway. Both E2F-1 and E2F-4 are rendered unstable by an epitope in the carboxyl terminus of the proteins, in close proximity to their pocket protein interaction surface. We show that binding of E2F-1 to pRb or E2F-4 to p107 or p130 protects E2Fs from degradation, causing the complexes to be stable. The increased stability of E2F-4 pocket protein complexes may contribute to the maintenance of active transcriptional repression in quiescent cells. Surprisingly, adenovirus transforming proteins, which release pocket protein-E2F complexes, also inhibit breakdown of free E2F. These data reveal an additional level of regulation of E2F transcription factors by targeted proteolysis, which is inhibited by pocket protein binding and adenovirus early region 1 transforming proteins.

References

Jan 1, 1992·Annual Review of Genetics·S Jentsch
Jan 10, 1991·Nature·M GlotzerM W Kirschner
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S W HiebertJ R Nevins
Aug 1, 1995·Current Biology : CB·D M Rubin, D Finley
Apr 1, 1995·Current Opinion in Cell Biology·M Hochstrasser
Jun 1, 1995·Molecular and Cellular Biology·E M HijmansR Bernards
Jun 1, 1995·Molecular and Cellular Biology·R BremnerR A Phillips
Jun 1, 1995·Genes & Development·R L BeijersbergenR Bernards
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·D G JohnsonJ R Nevins
Feb 1, 1995·Molecular and Cellular Biology·J YaglomD Finley
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·C SardetR A Weinberg
Aug 1, 1994·Genes & Development·B D DynlachtE Harlow
Nov 15, 1994·Genes & Development·D GinsbergD M Livingston
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Q QinP D Adams
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Wu, A J Levine
Dec 1, 1993·Genes & Development·D CobrinikR A Weinberg
Jul 1, 1996·Molecular and Cellular Biology·J BotzP Jansen-Dürr
Oct 18, 1996·The Journal of Biological Chemistry·G HateboerR Bernards

❮ Previous
Next ❯

Citations

Jan 1, 1997·Biopolymers·M BogyoH L Ploegh
Mar 10, 2001·Journal of Cellular Physiology·P R Yew
Dec 3, 1999·Progress in Biophysics and Molecular Biology·K L Craig, M Tyers
Oct 6, 2000·Biochimica Et Biophysica Acta·C A Gilchrist, R T Baker
May 22, 2002·Biochimica Et Biophysica Acta·James DeGregori
Jan 13, 1998·Biochimica Et Biophysica Acta·R Bernards
Feb 5, 2000·Biochimica Et Biophysica Acta·H Müller, K Helin
Jul 24, 2013·Nature Reviews. Molecular Cell Biology·Cosetta BertoliRobertus A M de Bruin
Jun 15, 2000·Journal of Neurochemistry·A L KurtzmanN Schechter
May 15, 2004·DNA and Cell Biology·Shohreh AminiBassel E Sawaya
Sep 26, 2008·Molecular Biology of the Cell·Isabella ManniGiulia Piaggio
Jul 21, 2009·Cardiovascular Research·Pasquale FasanaroFabio Martelli
Jun 17, 1998·The EMBO Journal·S NaviglioG F Draetta
Feb 17, 2000·The EMBO Journal·M A Martínez-BalbásT Kouzarides
Feb 1, 2005·Journal of Virology·Joel E SchaleyPatrick Hearing
Feb 25, 2000·Molecular and Cellular Biology·O Loughran, N B La Thangue
Feb 7, 2001·Molecular and Cellular Biology·S GaubatzD M Livingston
Apr 10, 2002·Molecular and Cellular Biology·Hong YangDavid M Livingston
Sep 2, 2005·Molecular and Cellular Biology·Abhishek DattaPradip Raychaudhuri
Jan 23, 2008·Cancer Cell International·Akiko UedaShunichiro Kubota
Oct 16, 2004·International Journal of Hematology·Gurveen SaberwalSuneel D Mundle
Jul 10, 2010·International Journal of Biological Sciences·Fikret Sahin, Todd L Sladek
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·Z M WangD M Livingston
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·F Martelli, D M Livingston
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·G J LindemanD Ginsberg
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·F MartelliS R Grossman
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·M R Campanero, E K Flemington

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.